Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | UMC | TSM |
|---|---|---|
| Price | $24.07 | $448.58 |
| Change today | ▼ 2.49% | ▲ 0.45% |
| Market cap | $60.59B | $2.33T |
| Return, 3 months | -12.6% | +1.8% |
| Return, year to date | +211.4% | +48.4% |
| Return, 1 year | +227.2% | +61.0% |
| P/E (TTM) | 23.3 | 33.4 |
| P/B | 4.3 | 11.5 |
| P/E percentile vs own 5y | 94th | 83rd |
| Dividend yield | – | 0.77% |
| Revenue growth (YoY, latest qtr) | +17.0% | +36.0% |
| Net profit growth (YoY) | +377.2% | +77.8% |
| Gross margin | 30.6% | 64.2% |
| Operating margin | 19.7% | 56.1% |
| Net margin | 32.8% | 49.9% |
| Return on equity | 21.0% | 40.3% |
| Analyst target vs. price | -45.2% | +23.1% |
| Analyst buy share | 0% | 86% |
| RSI (14) | 64 | 60 |
| 30-day volatility | 50.1% | 28.7% |
| Max drawdown, 1 year | -37.9% | -21.5% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.